Emcure Pharma IPO: The bidding for the initial public offering (IPO) of Emcure Pharmaceuticals Limited concluded on Friday last week, with the public issue worth ₹1,952.03 crore receiving a robust response from the Indian primary market investors. The Emcure Pharma IPO subscription status reveals that the public issue was oversubscribed […]
Emcure Pharma IPO GMP
Emcure Pharmaceuticals initial public offerings (IPO), which opened for subscription on Wednesday, was fully subscribed by the later half of the first day of bidding, driven by strong demand from non-institutional investors. The issue has been subscribed 1.22 times in the retail category and 1.92 times in the NII portion, […]